United States-based West Cancer Center & Research Institute, has named Matt Johnson as its new chief financial officer, it was reported on Tuesday.
Johnson joins West from Medical Anesthesia Group. He brings with him an extensive background in corporate finance, financial planning and analysis, strategic planning and risk management. He has more than 12 years' experience in finance; holding previous positions with Methodist Le Bonheur Healthcare, iBank and HealthChoice, a joint venture between Methodist Healthcare and MetroCare Physicians. He is an adjunct instructor of Healthcare Finance at Christian Brothers University.
Mitch Graves, CEO of West Cancer Center & Research Institute, said, 'Our West family could not more thrilled to welcome Matt Johnson to our team! He will undoubtedly make an immediate impact as we continuously operate and improve our clinical and fiscal practices. I am so impressed with Matt's ability to offer financial guidance in such a complex industry such as healthcare, while also maintaining a passionate and dedicated focus on serving patients across the region. I can't imagine a more exciting time to join our team. West is leading treatment innovation, research and new therapies in the oncology space here in the MidSouth. Matt and his financial team recognise and appreciate the unique opportunity they have to serve patients in a very tangible way. We are so excited to have him joining our team.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer